We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+58.39%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.77B
AUM Growth
+$909M
(+49%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
31.68%
Holding
209
New
25
Increased
86
Reduced
78
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$28.4M |
| 2 |
BlackLine
BL
|
+$24.3M |
| 3 |
HealthEquity
HQY
|
+$21.8M |
| 4 |
Workiva
WK
|
+$18M |
| 5 |
AXON
Axon Enterprise
AXON
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chegg
CHGG
|
+$46.7M |
| 2 |
Paycom
PAYC
|
+$27.2M |
| 3 |
Enphase Energy
ENPH
|
+$17.8M |
| 4 |
SPS Commerce
SPSC
|
+$16.7M |
| 5 |
Paylocity
PCTY
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.16% |
| 2 | Healthcare | 18.29% |
| 3 | Industrials | 13.17% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Communication Services | 6.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Editas Medicine
EDIT
$432M
| $2.08M | 0.08% |
70,305
+15,768
| +29% | +$412K |
|
152
Airgain
AIRG
$71.7M
| $2.06M | 0.07% |
+191,971
| New | +$1.64M |
|
|
CDTX
153
DELISTED
Cidara Therapeutics
CDTX
| $2.06M | 0.07% |
27,911
-854
| -3% | -$55.3K |
|
154
Fennec Pharmaceuticals
FENC
$380M
| $2.05M | 0.07% |
245,377
-24,832
| -9% | -$185K |
|
|
SHSP
155
DELISTED
SharpSpring, Inc.
SHSP
| $1.99M | 0.07% |
226,580
+24,631
| +12% | +$193K |
|
156
Standard BioTools
LAB
$310M
| $1.9M | 0.07% |
472,970
-269,745
| -36% | -$939K |
|
157
Expedia Group
EXPE
$37.7B
| $1.85M | 0.07% |
+22,518
| New | +$1.64M |
|
|
RWT
158
Redwood Trust
RWT
$574M
| $1.81M | 0.07% |
258,680
-103,806
| -29% | -$512K |
|
159
Intellia Therapeutics
NTLA
$1.68B
| $1.6M | 0.06% |
76,305
+16,963
| +29% | +$288K |
|
|
SIEN
160
DELISTED
Sientra, Inc.
SIEN
| $1.43M | 0.05% |
37,057
-43,940
| -54% | -$1.33M |
|
161
Xenon Pharmaceuticals
XENE
$6.21B
| $1.39M | 0.05% |
110,999
| – | – |
|
|
AKTS
162
DELISTED
Akoustis Technologies Inc
AKTS
| $1.37M | 0.05% |
164,979
+11,616
| +8% | +$89.8K |
|
163
Organogenesis Holdings
ORGO
$239M
| $1.34M | 0.05% |
350,280
+64,290
| +22% | +$232K |
|
164
Datadog
DDOG
$93.6B
| $1.19M | 0.04% |
13,658
-14,361
| -51% | -$874K |
|
165
Diamondback Energy
FANG
$55.7B
| $1.13M | 0.04% |
+26,952
| New | +$1.1M |
|
166
Angi Inc
ANGI
$186M
| $1.12M | 0.04% |
+9,234
| New | +$842K |
|
|
SGMO
167
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.11M | 0.04% |
123,951
+22,853
| +23% | +$212K |
|
|
NBRV
168
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $933K | 0.03% |
5,533
+4,497
| +434% | +$750K |
|
169
Bio-Rad Laboratories Class A
BIO
$9.48B
| $929K | 0.03% |
+2,058
| New | +$908K |
|
|
ABMD
170
DELISTED
Abiomed Inc
ABMD
| $919K | 0.03% |
3,802
-17,836
| -82% | -$3.58M |
|
171
Tyler Technologies
TYL
$13B
| $910K | 0.03% |
+2,621
| New | +$879K |
|
172
Xeris Biopharma Holdings
XERS
$1.46B
| $905K | 0.03% |
+340,403
| New | +$1.19M |
|
173
Johnson Outdoors
JOUT
$501M
| $892K | 0.03% |
+9,798
| New | +$700K |
|
|
PFIE
174
DELISTED
Profire Energy, Inc
PFIE
| $860K | 0.03% |
1,027,006
-342,465
| -25% | -$284K |
|
|
SOHO
175
DELISTED
Sotherly Hotels
SOHO
| $799K | 0.03% |
317,151
-34,418
| -10% | -$80K |
|
Similar funds
BC
AG
TA
ACP
TP
NSUP
ACG
CL
Granahan Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Granahan Investment Management held 209 positions worth $2.77B, up 49% from $1.86B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Granahan Investment Management's Q2 2020 filing shows 25 new, 86 increased, 78 reduced and 18 closed positions. Its largest new stake was BlackLine: 364,676 shares worth $30.2M. The largest sale was Chegg, an estimated $46.7M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.
- Granahan Investment Management's largest Q2 2020 buy was BlackLine: 364,676 shares worth $30.2M.
- Granahan Investment Management added most to Magnite in Q2 2020, an estimated $28.4M increase.
- Granahan Investment Management's biggest Q2 2020 reduction was Chegg, cutting an estimated $46.7M.
- Granahan Investment Management fully exited The Ensign Group in Q2 2020, selling an estimated $14M.
- Granahan Investment Management's ten largest holdings make up 32% of its $2.77B portfolio in Q2 2020.
- Granahan Investment Management opened 25 new positions and closed 18 in Q2 2020.
- Granahan Investment Management's portfolio value rose 49% quarter-over-quarter to $2.77B.
Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.